Neuronavigation-assisted versus conventional endoscopic endonasal transsphenoidal surgery for pituitary adenomas: a pilot randomized controlled trial

Abstract Purpose Evidence on the benefit of intraoperative neuronavigation in endoscopic endonasal transsphenoidal (EET) pituitary surgery remains mixed. We conducted a pilot randomized controlled trial comparing navigation-assisted and conventional EET surgery for pituitary adenomas, to estimate the effect size for a definitive multicentre trial. Methods At Ain Shams University (April 2025–February 2026), 57 patients with pituitary adenomas were assessed for eligibility; 7 were excluded for prior Gamma Knife radiosurgery. The remaining 50 were randomized 1:1 within strata of tumor size, functional status, and surgery status, with concealed computer-generated allocation. Outcome assessors, but not surgeons, were blinded. The primary outcome was extent of resection; secondary outcomes included operative time, blood loss, visual and hormonal outcomes, and complications. Results All 50 patients (25 per arm) were analyzed by intention-to-treat. Gross total resection was numerically higher with navigation (28.0% vs 16.0%; p = 0.496); adjusted for Knosp grade, the odds ratio was 2.66 (95% CI 0.41–17.06) versus a crude 2.04. Extent of resection was strongly associated with tumor size, functioning status, and Knosp grade; no giant adenoma achieved gross total resection. Blood loss was lower with navigation (median 250 vs 350 mL; p = 0.016), with no difference in operative time or added delay (p = 0.788). Conclusion Neuronavigation did not significantly improve extent of resection, though resection completeness trended favorably with navigation across most subgroups. The associated blood-loss reduction remains hypothesis-generating. A definitive, adequately powered multicentre trial is warranted. Trial registration: Pan African Clinical Trial Registry, PACTR202608562462156, registered retrospectively on 17 August 2026.

Authors

Institutions

Publication Details

Journal
Pituitary
Published
2026-11-13
DOI
https://doi.org/10.1007/s11102-026-01772-9
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Neuronavigation-assisted versus conventional endoscopic endonasal transsphenoidal surgery for pituitary adenomas: a pilot randomized controlled trial

Shebl Izz-alarab, Michael Zohney, Mohamed Mostafa Aziz, Abdelaleem Abdelwahab et al.
Pituitary
Pituitary Gland Disorders and Treatments
article

Neuronavigation-assisted versus conventional endoscopic endonasal transsphenoidal surgery for pituitary adenomas: a pilot randomized controlled trial

Shebl Izz-alarab, Michael Zohney, Mohamed Mostafa Aziz, Abdelaleem Abdelwahab, Ahmed Sammy
article en

Abstract

Abstract Purpose Evidence on the benefit of intraoperative neuronavigation in endoscopic endonasal transsphenoidal (EET) pituitary surgery remains mixed. We conducted a pilot randomized controlled trial comparing navigation-assisted and conventional EET surgery for pituitary adenomas, to estimate the effect size for a definitive multicentre trial. Methods At Ain Shams University (April 2025–February 2026), 57 patients with pituitary adenomas were assessed for eligibility; 7 were excluded for prior Gamma Knife radiosurgery. The remaining 50 were randomized 1:1 within strata of tumor size, functional status, and surgery status, with concealed computer-generated allocation. Outcome assessors, but not surgeons, were blinded. The primary outcome was extent of resection; secondary outcomes included operative time, blood loss, visual and hormonal outcomes, and complications. Results All 50 patients (25 per arm) were analyzed by intention-to-treat. Gross total resection was numerically higher with navigation (28.0% vs 16.0%; p = 0.496); adjusted for Knosp grade, the odds ratio was 2.66 (95% CI 0.41–17.06) versus a crude 2.04. Extent of resection was strongly associated with tumor size, functioning status, and Knosp grade; no giant adenoma achieved gross total resection. Blood loss was lower with navigation (median 250 vs 350 mL; p = 0.016), with no difference in operative time or added delay (p = 0.788). Conclusion Neuronavigation did not significantly improve extent of resection, though resection completeness trended favorably with navigation across most subgroups. The associated blood-loss reduction remains hypothesis-generating. A definitive, adequately powered multicentre trial is warranted. Trial registration: Pan African Clinical Trial Registry, PACTR202608562462156, registered retrospectively on 17 August 2026.

PituitaryVol. 29(6)
Ain Shams University (EG), Nasser Institute hospital (EG)
Good health and well-being
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon